Stay updated on Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page
- Check6 days agoChange DetectedThe page footer revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This is a minor maintenance update and does not change the study information presented on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows an updated revision number from v3.6.3 to v3.6.4, indicating a small site update rather than substantive content changes.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small version update that does not modify the study details.SummaryDifference0.1%

- Check49 days agoChange DetectedFooter revision tag updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check63 days agoChange DetectedRecruitment status is updated to indicate the study is no longer recruiting, and the page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating formatting for Intervention/Treatment and the Revision note to v3.6.0.SummaryDifference0.4%

- Check70 days agoChange DetectedA new revision label v3.5.5 appears in the page footer, replacing the previous v3.5.4.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib±Trastuzumab in Breast Cancer Brain Metastases Clinical Trial page.